Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 5Completed 5Withdrawn 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 2Leukemia 2Relapsed Pediatric Solid Tumor 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Mastocytosis, Systemic 1Lymphoma, T-Cell, Peripheral 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Gastrointestinal Stromal Tumors 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 18Rituximab 10fludarabine 8ibrutinib 6fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Radiotherapy 4Mycophenolic Acid 4Melphalan 4Filgrastim 4Cyclosporine 4Chlorambucil 4Antilymphocyte Serum 4Antigens, CD19 4Valproic Acid 3Sensitivity and Specificity 3Indium 3Immunotherapy, Adoptive 3Busulfan 3Alemtuzumab 3venetoclax 2sargramostim 2obinutuzumab 2navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 2epratuzumab 2Tacrolimus 2Radioimmunodetection 2Psychiatric Rehabilitation 2Pentostatin 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Lymphocytic, Chronic, B-Cell × Dasatinib × Clear all
NCT01051115 2011-08-31

D'ACCORD

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Unknown
35 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡